Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19512937 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects
Condition: HIV Infections
Interventions: Drug: Kaletra® (lopinavir/ritonavir);   Drug: Combivir® (lamivudine, zidovudine);   Drug: Sustiva® (efavirenz)

Indicates status has not been verified in more than two years